Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Cellectar Biosciences Inc have a median target of 13.50, with a high estimate of 28.00 and a low estimate of 7.00. The median estimate represents a 533.80% increase from the last price of 2.13.
High | 1,214.6% | 28.00 |
Med | 533.8% | 13.50 |
Low | 228.6% | 7.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | -8.38% |
Average growth rate | +32.79% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼